Press Releases
July 2, 2021
Panbela Announces Closing of $10.0 Million Bought Deal Offering of Common Stock
June 30, 2021
Panbela Increases Previously Announced Bought Deal Offering of Common Stock to $10.0 Million
June 29, 2021
Panbela Announces $5.0 Million Bought Deal Offering of Common Stock
June 4, 2021
Panbela Presents Clinical Data on Phase 1b Clinical Trial of SBP-101 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic PDA at 2021 ASCO Annual Meeting
View/download poster presentation »
May 26, 2021
Panbela Announces Company Founder Dr. Michael T. Cullen to Serve as Chairman of the Board of Directors
May 12, 2021
Panbela Provides Business Update and Reports Q1 2021 Financial Results
April 28, 2021
Panbela Schedules Conference Call on May 12, 2021 to Report 2021 First Quarter Financial Results
April 15, 2021
Panbela Announces Partial Clinical Hold Lifted on Phase I Polyamine Metabolic Inhibitor Study in Pancreatic Cancer
April 6, 2021